MCID: ADN021
MIFTS: 71

Adenomatous Polyposis Coli malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Eye diseases, Gastrointestinal diseases, Skin diseases, Fetal diseases, Bone diseases

Aliases & Classifications for Adenomatous Polyposis Coli

About this section
Sources:
50OMIM, 46NIH Rare Diseases, 23GeneTests, 52Orphanet, 68UniProtKB/Swiss-Prot, 25GTR, 12diseasecard, 48Novoseek, 66UMLS, 67UMLS via Orphanet, 29ICD10 via Orphanet, 38MESH via Orphanet, 35MedGen, 62The Human Phenotype Ontology
See all MalaCards sources

Aliases & Descriptions for Adenomatous Polyposis Coli:

Name: Adenomatous Polyposis Coli 50 12 66
Gardner Syndrome 50 46 23 52 66
Brain Tumor-Polyposis Syndrome 2 50 25 66
Familial Adenomatous Polyposis 1 50 25
Familial Adenomatous Polyposis 52 68
Gardner's Syndrome 46 25
Fap 52 68
Polyposis Coli and Multiple Hard and Soft Tissue Tumors 46
Apc-Related Attenuated Familial Adenomatous Polyposis 52
 
Intestinal Polyposis, Osteomas, Sebaceous Cysts 46
Apc-Related Attenuated Familial Polyposis Coli 52
Colorectal Adenomatous Polyposis 52
Turcot Syndrome with Polyposis 52
Apc-Related Attenuated Fap 52
Familial Polyposis Coli 52
Gardners Syndrome 48
Apc-Related Afap 52

Characteristics:

Orphanet epidemiological data:

52
familial adenomatous polyposis:
Inheritance: Autosomal dominant,Autosomal recessive; Prevalence: 1-9/100000 (Europe),1-5/10000 (Denmark),1-9/100000 (Denmark),1-9/100000 (Sweden),1-5/10000 (Finland),1-9/100000 (Finland),1-5/10000 (United Kingdom),1-9/100000 (United Kingdom),1-9/1000000 (Australia),1-9/100000 (Australia); Age of onset: Adult; Age of death: adult
apc-related attenuated familial adenomatous polyposis:
Inheritance: Autosomal dominant,Autosomal recessive
turcot syndrome with polyposis:
Inheritance: Autosomal dominant; Age of onset: All ages

HPO:

62
adenomatous polyposis coli:
Inheritance: autosomal dominant inheritance
Onset and clinical course: variable expressivity


Classifications:



External Ids:

OMIM50 175100
UMLS via Orphanet67 C0032580, C0017097
ICD10 via Orphanet29 D12.6
MESH via Orphanet38 D011125, D005736

Summaries for Adenomatous Polyposis Coli

About this section
NIH Rare Diseases:46 Gardner syndrome is a form of familial adenomatous polyposis (fap) that is characterized by multiple colorectal polyps and various types of tumors, both benign (noncancerous) and malignant (cancerous). people affected by gardner syndrome have a high risk of developing colorectal cancer at an early age. they are also at an increased risk of developing other fap-related cancers, such as those of the small bowel, stomach, pancreas, thyroid, central nervous system, liver, bile ducts, and/or adrenal gland. other signs and symptoms of gardner syndrome include dental abnormalities; osteomas (benign bone growths); various skin abnormalities such as epidermoid cysts, fibromas (a benign tumor of the connective tissue), and lipomas; and desmoid tumors. it is caused by changes (mutations) in the apc gene and inherited in an autosomal dominant manner. although there is no cure for gardner syndrome, management options are available to reduce the risk of cancer. these may include high risk screening, prophylactic surgeries and/or certain types of medications. last updated: 1/14/2015

MalaCards based summary: Adenomatous Polyposis Coli, also known as gardner syndrome, is related to medulloblastoma and hepatocellular carcinoma, and has symptoms including adenomatous colonic polyposis, intestinal polyposis and duodenal polyposis. An important gene associated with Adenomatous Polyposis Coli is APC (APC, WNT Signaling Pathway Regulator), and among its related pathways are Regulation of Microtubule Cytoskeleton and N-cadherin signaling events. The drug celecoxib has been mentioned in the context of this disorder. Affiliated tissues include colon, skin and thyroid, and related mouse phenotypes are limbs/digits/tail and craniofacial.

UniProtKB/Swiss-Prot:68 Familial adenomatous polyposis: A cancer predisposition syndrome characterized by adenomatous polyps of the colon and rectum, but also of upper gastrointestinal tract (ampullary, duodenal and gastric adenomas). This is a viciously premalignant disease with one or more polyps progressing through dysplasia to malignancy in untreated gene carriers with a median age at diagnosis of 40 years.

OMIM:50 Familial adenomatous polyposis-1 is an autosomal dominant disorder characterized by predisposition to cancer. Affected... (175100) more...

Wikipedia:69 This article refers to the tumor suppressor APC, in which mutations lead to colon cancer. For the... more...

Related Diseases for Adenomatous Polyposis Coli

About this section

Diseases related to Adenomatous Polyposis Coli via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 98)
idRelated DiseaseScoreTop Affiliating Genes
1medulloblastoma29.3APC, AXIN1, CTNNB1, MYC
2hepatocellular carcinoma27.8APC, AXIN1, CCND1, CDH1, CTNNB1, GLUL
3colorectal cancer26.6APC, AXIN1, AXIN2, CCND1, CDH1, CTNNB1
4colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas12.3
5familial adenomatous polyposis12.0
6samson gardner syndrome11.9
7attenuated familial adenomatous polyposis11.6
8mismatch repair cancer syndrome11.3
9mutyh-associated polyposis11.3
10adenoma10.5
11breast cancer10.4
12malignant hyperthermia susceptibility10.4APC, MUTYH
13ehlers-danlos syndrome, type viic10.3APC, CTNNB1, GLUL
14hepatocellular adenoma10.3
15mature b-cell neoplasm10.3AXIN1, AXIN2, CTNNB1
16colver steer godman syndrome10.3APC, CDH1, MUTYH
17colorectal adenoma10.3
18oral squamous cell carcinoma10.3
19thyroiditis10.3
20neuronitis10.3
21desmoplastic infantile astrocytoma10.2APC, CCND1, CTNNB1
22acquired amegakaryocytic thrombocytopenia10.2APC, MUTYH
23plethora of newborn10.2CDH1, CTNNB1
24lung cancer10.2
25desmoid tumor10.2
26tumor predisposition syndrome10.2APC, CDH1, MUTYH
27retinoblastoma10.1
28ulcerative colitis10.1
29ameloblastoma10.1
30colitis10.1
31male reproductive organ benign neoplasm10.1CCND1, CTNNB1, MUTYH
32hodgkin's granuloma10.0CCND1, CDH1, CTNNB1
33lobular neoplasia10.0CCND1, CDH1, CTNNB1
34schizophrenia10.0
35parathyroid carcinoma10.0
36adult t-cell leukemia10.0
37gastric cancer10.0
38hepatitis10.0
39hepatitis b10.0
40leukemia10.0
41colorectal adenocarcinoma10.0
42autism spectrum disorder10.0
43lymphoma10.0
44stomach cancer10.0
45fourth cranial nerve palsy10.0
46sarcoma10.0
47myopia10.0
48esophagitis10.0
49prostatitis10.0
50neuroendocrine tumor10.0

Graphical network of the top 20 diseases related to Adenomatous Polyposis Coli:



Diseases related to adenomatous polyposis coli

Symptoms for Adenomatous Polyposis Coli

About this section

Symptoms by clinical synopsis from OMIM:

175100

Clinical features from OMIM:

175100

Symptoms:

 52 (show all 13)
  • neoplasm
  • colon cancer
  • multiple gastric polyps
  • delayed eruption of teeth
  • multiple lipomas
  • duodenal polyposis
  • adenomatous colonic polyposis
  • irregular hyperpigmentation
  • fibroma
  • odontoma
  • increased number of teeth
  • neoplasm of the central nervous system
  • sarcoma

HPO human phenotypes related to Adenomatous Polyposis Coli:

(show all 32)
id Description Frequency HPO Source Accession
1 adenomatous colonic polyposis hallmark (90%) HP:0005227
2 intestinal polyposis hallmark (90%) HP:0200008
3 duodenal polyposis typical (50%) HP:0004783
4 neoplasm of the colon typical (50%) HP:0100273
5 colon cancer frequent (33%) HP:0003003
6 multiple gastric polyps frequent (33%) HP:0004394
7 adrenocortical adenoma 13% HP:0008256
8 desmoid tumors 10% HP:0100245
9 carious teeth occasional (7.5%) HP:0000670
10 delayed eruption of teeth occasional (7.5%) HP:0000684
11 unerupted tooth occasional (7.5%) HP:0000706
12 multiple lipomas occasional (7.5%) HP:0001012
13 neoplasm of the nervous system occasional (7.5%) HP:0004375
14 irregular hyperpigmentation occasional (7.5%) HP:0007400
15 congenital hypertrophy of retinal pigment epithelium occasional (7.5%) HP:0007649
16 fibroadenoma of the breast occasional (7.5%) HP:0010619
17 increased number of teeth occasional (7.5%) HP:0011069
18 sarcoma occasional (7.5%) HP:0100242
19 osteoma occasional (7.5%) HP:0100246
20 odontogenic neoplasm occasional (7.5%) HP:0100612
21 epidermoid cyst occasional (7.5%) HP:0200040
22 duodenal adenocarcinoma 4% HP:0006771
23 hepatoblastoma 1.6% HP:0002884
24 medulloblastoma very rare (1%) HP:0002885
25 papillary thyroid carcinoma very rare (1%) HP:0002895
26 hyperpigmentation of the skin HP:0000953
27 multiple lipomas HP:0001012
28 small intestine carcinoid HP:0006722
29 adrenocortical carcinoma HP:0006744
30 astrocytoma HP:0009592
31 keloids HP:0010562
32 odontoma HP:0011068

UMLS symptoms related to Adenomatous Polyposis Coli:


abdominal pain, diarrhea

Drugs & Therapeutics for Adenomatous Polyposis Coli

About this section

Drugs for Adenomatous Polyposis Coli (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CelecoxibPhase 4, Phase 2, Phase 3, Phase 1427169590-42-52662
Synonyms:
169590-42-5
184007-95-2
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
AC-4228
AC1L1E6K
AI-525
BIDD:GT0408
BRD-K02637541-001-02-4
BSPBio_003596
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
C07589
C105934
C17H14F3N3O2S
CCRIS 8679
CEL
CEP-33222
CHEBI:41423
CHEMBL118
CID2662
CPD000550473
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
Celecoxib
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxibum
Celocoxib
Célécoxib
D00567
DB00482
DivK1c_000893
Eurocox
FT-0080064
HMS1922G14
HMS2089L18
HMS2093I07
HMS502M15
HSDB 7038
I01-1033
IDI1_000893
KBio1_000893
KBio2_000912
 
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
LS-31667
MLS001165684
MLS001195656
MLS001304708
Medicoxib
MolPort-002-885-815
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCI60_041049
NINDS_000893
NSC719627
Onsenal
P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
Pfizer brand of celecoxib
S1261_Selleck
SAM002589995
SC 58635
SC-58553, SC-58635
SC-58635
SC58635
SMR000550473
SPBio_001512
SPECTRUM1503678
Solexa
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
Spectrum_000432
TL8001323
TPI-336
UNM-0000305813
Xilebao
YM 177
YM-177
YM177
ZINC02570895
cMAP_000027
celecoxib
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
2
ErythromycinPhase 492114-07-812560
Synonyms:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
,10-dione
114-07-8
3''-O-demethylerythromycin
374700-25-1
45673_FLUKA
45674_FLUKA
79235-06-6
82343-12-2
A/T/S
AC-12744
AC1L1FIQ
AC1L1QK7
AC1L1ZUR
AC1O8PVA
AC1Q2UA1
AC1Q6O1S
AI3-50138
AR-1A4414
AR-1H0723
Abboticin
Abomacetin
Acneryne
Acnesol
Ak-Mycin
Ak-mycin
Akne Cordes Losung
Akne-Mycin
Akne-mycin (TN)
Aknederm Ery Gel
Aknemycin
Aknin
AustriaS
BB_NC-1332
BIDD:GT0017
BPBio1_000312
BSPBio_000282
BSPBio_002480
Benzamycin
Benzamycin Pak
Bristamycin
C-Solve-2
C01912
C37H67NO13
CCRIS 9078
CHEBI:42355
CHEMBL532
CID12560
CID3255
CID6713919
CID8233
D00140
DB00199
Del-Mycin
Derimer
Deripil
DivK1c_000294
DivK1c_000397
DivK1c_000702
Dotycin
Dumotrycin
E- mycin, Erycin, Robimysin
E-Base
E-Base (base)
E-Glades
E-Mycin
E-Mycin (base)
E-Solve 2
E0751
E0774_SIAL
E5389_SIGMA
E6376_SIAL
E7904_SIGMA
EINECS 204-040-1
EM
EMU
ERY
ERYC
ERYC (base)
ERYTHROMYCIN STEARATE
ETS
Emgel
Emu-V
Emu-Ve
Emuvin
Emycin
Endoeritrin
Erecin
Erimycin-T
Erisone
Eritomicina
Eritrocina
Eritromicina
Eritromicina [INN-Spanish]
Ermycin
Eros
Ery-B
Ery-Diolan
Ery-Sol
Ery-Tab
Ery-Tab (base)
Ery-maxin
Eryacne
Eryacnen
Eryc
Eryc (TN)
Eryc 125
Eryc Sprinkles
Eryc-125
Eryc-250
Erycen
Erycette
Erycin
Erycinum
Eryderm
Erydermer
Erygel
Erygel (TN)
Eryhexal
Erymax
Erymed
Erypar
Erysafe
Erytab
Erythra-Derm
Erythro
Erythro-Statin
Erythro-Teva
Erythrocin
Erythrocin Stearate
Erythroderm
Erythrogran
Erythroguent
Erythromast 36
Erythromid
Erythromycin
Erythromycin & VRC3375
Erythromycin (JP15/USP/INN)
 
Erythromycin A
Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279
Erythromycin B
Erythromycin C
Erythromycin Lactate
Erythromycin Ointment
Erythromycin Stearate
Erythromycin [INN:BAN:JAN]
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin intravenous
Erythromycin lactobionate
Erythromycin oxime
Erythromycin sodium lauryl sulfate
Erythromycin, compd. with monododecyl sulfate, sodium salt
Erythromycine
Erythromycine [INN-French]
Erythromycinum
Erythromycinum [INN-Latin]
Erytop
Erytrociclin
Ethril 250
HMS1568O04
HMS1920M04
HMS2091D05
HMS500O16
HSDB 3074
I06-0245
IDI1_000294
IDI1_000397
IDI1_000702
Ilocaps
Ilosone
Ilosone (estolate)
Iloticina
Ilotycin
Ilotycin Gluceptate
Ilotycin T.S
Ilotycin T.S.
Inderm
Inderm Gel
IndermRetcin
KBio1_000294
KBio1_000397
KBio1_000702
KBio2_000555
KBio2_001139
KBio2_003123
KBio2_003707
KBio2_005691
KBio2_006275
KBioGR_001175
KBioSS_000555
KBioSS_001139
KST-1A8261
Kesso-Mycin
LMPK04000006
LS-187077
LS-64648
Latotryd
Lederpax
MLS001066618
Mephamycin
Mercina
MolPort-000-772-161
MolPort-002-507-378
MolPort-003-933-429
N-Methylerythromycin A
NCGC00179619-01
NCI-C55674
NINDS_000294
NINDS_000397
NINDS_000702
NSC 55929
NSC55929
Oftalmolosa Cusi Eritromicina
Oftamolets
PCE Dispertab (base)
Paediathrocin
Pantoderm
Pantodrin
Pantomicina
Pce
Pce (TN)
Pfizer-e
Pharyngocin
Prestwick0_000151
Prestwick1_000151
Prestwick2_000151
Prestwick3_000151
Prestwick_205
Primacine
Propiocine
Proterytrin
R-P Mycin
Retcin
Robimycin
Romycin
SBB057401
SMP1_000119
SMR000544946
SPBio_000778
SPBio_001226
SPBio_002221
SPECTRUM1500280
STK249736
Sans-acne
Sansac
Serp-AFD
Skid Gel E
Spectrum2_000759
Spectrum2_001263
Spectrum4_000538
Spectrum5_001596
Spectrum_000115
Spectrum_000659
Staticin
Staticin (TN)
Stiemicyn
Stiemycin
Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin
T-Stat
T-stat (TN)
Taimoxin-F
Theramycin Z
Tiloryth
Tiprocin
Torlamicina
UNII-63937KV33D
Udima Ery Gel
Wemid
Wyamycin S
adecane-2,10-dione (non-preferred name)
bmse000664
erythro
erythromycin
nchembio.285-comp13
3
RofecoxibPhase 4, Phase 2, Phase 331162011-90-75090
Synonyms:
162011-90-7
186912-82-3
3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one
3-Phenyl-4-(4-(methylsulfonyl)phenyl))-2(5H)-furanone
3-phenyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone
4-(4-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone
4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one
4-(p-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone
4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone
4-[4-(methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one
AC-13144
AC1L1JL6
AKOS000280931
BIDD:GT0399
BRD-K21733600-001-02-6
BSPBio_002705
Bio-0094
C07590
C116926
C17H14O4S
CCRIS 8967
CHEBI:8887
CHEMBL122
CID5090
CPD000466331
Cahill May Roberts brand of rofecoxib
Ceoxx
D00568
DB00533
DivK1c_006765
FT-0081390
HMS1922H11
HMS2051G16
HMS2089H20
HMS2093E04
HSDB 7262
I01-1042
Jsp003237
KBio1_001709
KBio2_000559
KBio2_002345
KBio2_003127
KBio2_004913
KBio2_005695
KBio2_007481
KBio3_002205
KBio3_002825
KBioGR_001242
 
KBioGR_002345
KBioSS_000559
KBioSS_002348
KS-1107
L000912
LS-70511
MK 0966
MK 0996
MK 966
MK 996
MK-0966
MK-966
MK0966
MLS000759440
MLS001165770
MLS001195623
MLS001424113
MSD brand of rofecoxib
Merck Frosst brand of rofecoxib
Merck Sharp & Dhome brand of rofecoxib
Merck brand of rofecoxib
MolPort-000-883-878
MolPort-006-817-786
NCGC00095118-01
NCGC00095118-02
NCGC00095118-03
NCGC00095118-04
NCI60_041175
NSC720256
Rofecoxib (JAN/USAN/INN)
SAM001246617
SMR000466331
SPBio_000492
SPECTRUM1504235
STK635144
SpecPlus_000669
Spectrum2_000446
Spectrum3_001153
Spectrum4_000631
Spectrum5_001598
Spectrum_000119
UNII-0QTW8Z7MCR
Vioxx
Vioxx (TN)
Vioxx (trademark)
Vioxx Dolor
ZINC00007455
cMAP_000024
refecoxib
rofecoxib
4
SulindacPhase 3, Phase 23738194-50-25352, 1548887
Synonyms:
(E)-(1)-5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-((p-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-[[4-(methyl-sulfinyl)phenyl]methylene]-1H-indene-3-acetic acid
(Z)-5-Fluoro-2-methyl-1-[p-(methylsulfinyl)benzylidene]indene-3-acetic acid
2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
2-[6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid
32004-68-5
38194-50-2
5-Fluoro-2-methyl-1-((4-(methylsulphinyl)phenyl)methylene)-1H-indene-3-acetic acid
53933-60-1
6301-55-9
9000-14-0
AB00513800
AC-4550
AC1L1K5T
AC1LU7GU
AC1LU7GY
AC1Q6YHK
AKOS004119989
AR-1A9609
Aclin
Aflodac
Alphapharm Brand of Sulindac
Apo Sulin
Apo-Sulin
Apotex Brand of Sulindac
Arthrobid
Arthrocine
BB_SC-1128
BPBio1_000315
BRD-A03427350-001-01-3
BRD-A13946108-001-04-9
BRN 2951842
BSPBio_000285
BSPBio_002890
C01531
C20H17FO3S
CAS-38194-50-2
CCRIS 3305
CHEBI:9352
CHEMBL1376
CID1548885
CID1548887
CID5352
CPD000326718
Cahill May Roberts Brand of Sulindac
Chemia Brand of Sulindac
Chibret
Clinoril
Clinoril (TN)
Copal
Copal resin
Copal rosin varnish
Copals
D00120
D013467
DB00605
DivK1c_000601
EINECS 232-527-9
EINECS 250-893-8
EINECS 253-819-2
EINECS 258-873-0
EU-0101070
Gum copal
HMS1568O07
HMS1921C11
HMS2089J04
HMS2092K15
HMS501O03
I06-0523
IDI1_000601
KBio1_000601
KBio2_001506
KBio2_002320
KBio2_004074
KBio2_004888
KBio2_006642
KBio2_007456
KBio3_002110
KBio3_002800
KBioGR_001571
 
KBioGR_002320
KBioSS_001506
KBioSS_002322
KST-1B6530
Kenalin
Kendrick Brand of Sulindac
Klinoril
LS-81610
Lopac-S-8139
Lopac0_001070
MK 231
MK-231
MK231
MLS001056554
MLS001304027
MLS002207124
Merck Brand of Sulindac
Merck Sharp & Dohme Brand of Sulindac
Mobilin
MolPort-002-507-760
MolPort-003-666-287
NCGC00015970-01
NCGC00015970-02
NCGC00015970-03
NCGC00015970-08
NCGC00025268-01
NCGC00025268-02
NCGC00025268-03
NCGC00094349-01
NCGC00094349-02
NINDS_000601
Novo Sundac
Novo-Sundac
Novopharm Brand of Sulindac
Nu Pharm Brand of Sulindac
Nu Sulindac
Nu-Pharm Brand of Sulindac
Nu-Sulindac
Prestwick0_000073
Prestwick1_000073
Prestwick2_000073
Prestwick3_000073
Prestwick_456
Resin copal
S 8139
S2007_Selleck
S4429_SIAL
S8139_SIAL
S8139_SIGMA
SAM002554933
SBB058181
SMR000043852
SMR000326718
SPBio_001451
SPBio_002206
SPECTRUM1500556
STK802068
Spectrum2_001326
Spectrum3_001365
Spectrum4_000876
Spectrum5_001024
Spectrum_001026
Sulindac
Sulindac (JAN/USP/INN)
Sulindac [USAN:BAN:INN:JAN]
Sulindac sulfoxide
Sulindaco
Sulindaco [INN-Spanish]
Sulindacum
Sulindacum [INN-Latin]
Sulindal
Tocris-1707
UNII-184SNS8VUH
UNII-M5221THD3M
UNM-0000306136
Z-5-Fluoro-2-methyl-1-[p-(methlsulfinyl)benzylidene]indene-3-acetic acid
[(1E)-5-fluoro-2-methyl-1-{[4-(methylsulfinyl)phenyl]methylidene}-1H-inden-3-yl]acetic acid
cMAP_000021
cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid
cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid
cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl)benzylidene)indene-3-acetic acid
sulindac
{(1E)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
{(1Z)-5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1H-inden-3-yl}acetic acid
{5-fluoro-2-methyl-1-[4-(methylsulfinyl)benzylidene]-1h-inden-3-yl}acetic acid
5
Ursodeoxycholic acidPhase 2, Phase 383128-13-231401
Synonyms:
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oate
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
(3a,5b,7b)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
128-13-2
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
3,7-Dihydroxycholan-24-oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3a,7b-Dihydroxy-5b-cholan-24-oate
3a,7b-Dihydroxy-5b-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
4-10-00-01604 (Beilstein Handbook Reference)
50809-41-1
5beta-Cholan-24-oic acid-3alpha,7beta-diol
5beta-Cholanic Acid-3alpha,7beta-diol
7-beta-Hydroxylithocholic acid
7beta-Hydroxylithocholic acid
80225-86-1
AB00513977
AC-18919
AC-2081
AC1L1LJH
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
Acido ursodeossicolico
Acido ursodeossicolico [Italian]
Acido ursodeoxicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum
Acidum ursodeoxycholicum [INN-Latin]
Actigall
Actigall (TN)
Antigall
Arsacol
BB_NC-2372
BPBio1_001052
BRN 3219888
BSPBio_000956
C07880
C24H40O4
CCRIS 5502
CHEBI:9907
CHEMBL1551
CHEMBL73390
CID11516715
CID31401
CPD-10534
CPD000058403
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- (9CI)
Cholit-ursan
D00734
DB01586
Delursan
Deoxyursocholic Acid
Destolit
Deursil
Dom-ursodiol c
EINECS 204-879-3
HMS1570P18
 
ISO-URSODEOXYCHOLIC ACID
IU5
LMST04010033
LS-53033
Litursol
Lyeton
MLS000028461
MLS001066373
MolPort-001-794-630
MolPort-005-932-884
NCGC00179363-01
NCI60_028904
NSC 657950
NSC 683769
PHL-ursodiol c
PMS-ursodiol c
Peptarom
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
S1643_Selleck
SAM002264653
SMP2_000012
SMR000058403
SPBio_003105
Sodium Ursodeoxycholate
Solutrat
U-9000
U0030
U5127_SIGMA
UDCA
UDCS
UNII-724L30Y2QR
URSODEOXYCHOLIC ACID
UrSO
Urosdesoxycholate
Urosdesoxycholic acid
Urosiol
Ursacholic Acid
Ursacol
Urso
Urso (TN)
Urso 250
Urso DS
Urso Forte
Ursobilin
Ursochol
Ursodamor
Ursodeoxy cholic acid
Ursodeoxycholate
Ursodeoxycholic acid
Ursodeoxycholic acid (JP15/INN)
Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol
Ursodeoxycholicacid
Ursodesoxycholic acid
Ursodexycholate
Ursodexycholic Acid
Ursodexycholic acid
Ursodiol
Ursodiol (USP)
Ursodiol [USAN]
Ursofalk
Ursolvan
Ursosan
chenodeoxycholic acid
ursodeoxycholate
ursodiol
6
LoperamidePhase 314053179-11-63955
Synonyms:
2-methoxyethyl1-methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
34552-83-5 (mono-hydrochloride)
4-(4-Chlorophenyl)-N,N-dimethyl-.alpha.,.alpha.-diphenyl-4-hydroxy-1-piperidinebutanamide
4-(4-Chlorophenyl)-N,N-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide
5-21-02-00379 (Beilstein Handbook Reference)
53179-11-6
AB00053697
AC1L1H38
AKOS000573892
Apo-Loperamide
BAS 01889668
BPBio1_000274
BRD-K61250553-001-02-9
BRD-K61250553-003-05-8
BRN 1558273
BSPBio_000248
BSPBio_001381
BSPBio_002769
Bio1_000082
Bio1_000571
Bio1_001060
Bio2_000101
Bio2_000581
C07080
C29H33ClN2O2
CAS-34552-83-5
CBiol_001796
CHEBI:162259
CHEBI:6532
CHEMBL841
CID3955
D08144
DB00836
Diamide (TN)
Diarr-Eze
DivK1c_000215
EINECS 258-416-5
HMS1791F03
HMS1989F03
HMS2089C13
IDI1_000215
IDI1_033851
Imodium A-D
Imodium A-D Caplets
Ioperamide
KBio1_000215
KBio2_000101
KBio2_000854
KBio2_002669
KBio2_003422
KBio2_005237
KBio2_005990
KBio3_000201
 
KBio3_000202
KBio3_001989
KBioGR_000101
KBioGR_001685
KBioSS_000101
KBioSS_000854
Kaopectate II
L000709
LS-114352
Lopac-L-4762
Lopac0_000708
Loperacap
Loperamid
Loperamida
Loperamida [INN-Spanish]
Loperamide (INN)
Loperamide Monohydrochloride
Loperamide [INN:BAN]
Loperamide hydrochloride
Loperamidum
Loperamidum [INN-Latin]
Lopéramide
Maalox Anti-Diarrheal
MolPort-001-969-016
NCGC00015608-01
NCGC00015608-08
NCGC00016828-01
NCGC00024818-01
NCGC00024818-02
NCGC00024818-03
NCGC00024818-04
NCGC00024818-05
NINDS_000215
Nu-Loperamide
Oprea1_109220
PMS-Loperamide
Pepto Diarrhea Control
Prestwick0_000144
Prestwick1_000144
Prestwick2_000144
Prestwick3_000144
R-18553
Rho-Loperamide
SPBio_001816
SPBio_002187
ST095179
Spectrum2_001738
Spectrum3_001015
Spectrum4_001143
Spectrum5_001374
Spectrum_000374
Tocris-0840
UNII-6X9OC3H4II
loperamide
nchembio.559-comp8
nchembio.79-comp7
7
EflornithinePhase 3, Phase 23570052-12-93009
Synonyms:
(RS)-2,5-diamino-2-(difluoromethyl)pentanoic acid
.alpha.-DFMO HCl
2,5-diamino-2-(difluoromethyl)pentanoic acid
2,5-diamino-2-(difluoromethyl)pentanoic acid hydrate hydrochloride
2,5-diamino-2-(difluoromethyl)pentanoic acid hydrochloride
2-(Difluoromethyl)-DL-ornithine
2-(Difluoromethyl)-DL-ornithine HCl
2-(Difluoromethyl)-DL-ornithine hydrochloride
2-(Difluoromethyl)-DL-ornithine monohydrochloride
2-(Difluoromethyl)-DL-ornithine monohydrochloride, monohydrate
2-(Difluoromethyl)-DL-ornithine monohydrochloride.monohydrate
2-(Difluoromethyl)ornithine
2-(Difluoromethyl)ornithine hydrochloride hydrate
67037-37-0
68278-23-9
70050-56-5
70052-12-9
70052-12-9 (Parent)
96020-91-6
96020-91-6 (mono-hydrochloride, monohydrate)
AC-388
AC-5497
AC1L1EYW
AC1L1M41
AC1L9B1G
BMS 203522
BRN 2250529
C07997
C6H12F2N2O2.HCl.H2O
CCRIS 3295
CCRIS 3718
CCRIS 5805
CHEBI:41948
CHEMBL1201037
CHEMBL536971
CID3009
CID441361
CID57004
CPP-1X
D,L-alpha-Difluoromethylornithine
D,L-alpha-Difluoromethylornithine hydrochloride
D00829
D07883
D193_SIGMA
DFMO
DFMO (growth regulator)
DFMO HCl
DFMO hydrochloride
DFMO hydrochloride hydrate
DL-.alpha.-Difluoromethylornithine
DL-Ornithine, 2-(difluoromethyl)-, monohydrochloride
DL-Ornithine, 2-(difluoromethyl)-, monohydrochloride, monohydrate
DL-alpha-(Difluoromethyl)ornithine
DL-alpha-Difluoromethylornithine
DL-alpha-Difluoromethylornithine hydrochloride
 
DL-alpha-Difluoromethylornithine hydrochloride hydrate
DL-alpha-Difluoromethylornithine, Hydrochloride
Difluoromethylornithine
Difluromethylornithine
EFLORNITHINE
EFLORNITHINE HYDROCHLORIDE
EINECS 269-532-0
EU-0100429
Eflornithine (INN)
Eflornithine HCl
Eflornithine [INN:BAN]
Eflornithine hydrochloride (USAN)
Eflornithine hydrochloride [USAN]
Eflornithine hydrochloride hydrate
Eflornithine hydrochloride monohydrate
Eflornithinum
Eflornithinum [Latin]
Eflornitina
Eflornitina [Spanish]
FT-0082608
FT-0082826
HSCI1_000267
I06-0316
I06-0530
LS-178282
LS-185084
LS-7332
LS-98405
Lopac0_000429
MDL 71,782 A
MDL 71782
MDL-71782A
MLS000069341
MLS001332583
MolPort-003-940-991
N-Difluoromethylornithine
NCGC00015316-03
NCGC00093850-01
NCGC00162152-01
NSC270295
NSC337250
Ornidyl
Ornidyl (TN)
Ornithine, 2-(difluoromethyl)-, monohydrochloride
RMI 71782
RMI-71782
SBB066102
SMR000058442
UNII-4NH22NDW9H
UNII-ZQN1G5V6SR
Vaniqa
alpha,delta-Diamino-alpha-(difluoromethyl)valeric acid
alpha-(Difluoromethyl)-DL-ornithine
alpha-Difluoromethylornithine
alpha-Difluoromethylornithine hydrochloride
dfmo
α-difluoromethylornithine
8dolutegravirPhase 31331051375-16-654726191
9COLANutraceuticalPhase 2, Phase 3, Phase 11824
10
ornithineNutraceuticalPhase 3, Phase 26770-26-86262
Synonyms:
(+)-S-Ornithine
(S)-2,5-Diaminopentanoate
(S)-2,5-Diaminopentanoic acid
(S)-2,5-diaminovaleric acid
(S)-Ornithine
(S)-a,D-Diaminovalerate
 
(S)-a,D-Diaminovaleric acid
(S)-alpha,delta-Diaminovaleric acid
(S)-ornithine
(S)-α,δ-diaminovaleric acid
5-Amino-L-Norvaline
L-(-)-Ornithine
L-Ornithine
11
erlotinib hydrochloridePhase 2793183319-69-9176871
Synonyms:
 
erlotinib hydrochloride
12
EverolimusPhase 1, Phase 21863159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
Zortress
everolimus
13
MetforminPhase 21701657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
14
MiconazolePhase 1, Phase 2357322916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
15
CurcuminPhase 2131458-37-7969516
Synonyms:
1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione
C.I. Natural Yellow 3
CI Natural Yellow 3
Cucurmin
Curcuma
Curcumin
Curcumin I
Diferaloylmethane
Diferuloylmethane
Gelbwurz
Golden seal
Haidr
Halad
Haldar
Halud
Hydrastis
 
Indian saffron
Indian turmeric
Kacha haldi
Kurkumin [czech]
Merita earth
Natural yellow 3
Orange root
Safran D'inde
Souchet
Terra merita
Tumeric yellow
Turmeric
Turmeric (>98% curcurmin)
Turmeric oleoresin (79%-85% curcumin)
Turmeric yellow
Yellow ginger
Yellow puccoon
Yellow root
Yo-kin
Zlut prirodni 3 [Czech]
16
sirolimusPhase 1, Phase 2186353123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
17
Vitamin ANutraceuticalPhase 245011103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
18retinolNutraceuticalPhase 2450
19
InulinNutraceuticalPhase 21029005-80-524763
Synonyms:
(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-2-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethy
189444-25-5
887747-94-6
AC1L2NNM
AI3-19506
CID24763
DB00638
 
EINECS 232-684-3
INULIN
Inulin USP 27
Inulin [BAN]
Inulin and sodium chloride
Inulin from Jerusalem artichokes
LS-186416
LS-187349
20
AspirinPhase 1107450-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
 
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
21
BevacizumabPhase 11938216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
22
Cidofovir31113852-37-260613
Synonyms:
(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine
(S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid
(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine
(S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
(S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine
(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid
(S)-HPMPC
(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
113852-37-2
120362-37-0 (hydrochloride salt)
149394-66-1
AC-1666
AC1L1TLB
AC1Q6C68
AKOS005145721
C8H14N3O6P
CDV
CHEBI:3696
 
CHEMBL152
CID60613
Cidofovir
Cidofovir (Vistide)
Cidofovir (anhydrous)
Cidofovir Anhydrous
Cidofovir anhydrous
Cidofovirum
DB00369
Forvade
GS 0504
GS 504
GS-0504
GS-504
GS504
HPMPC
HSDB 7115
LS-106432
MolPort-005-935-597
NSC742135
S1516_Selleck
UNII-768M1V522C
Vistide
Vistide, Cidofovir
[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid
[[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
23Acyclovir176
24Fluorides405
25Estradiol valerate1250979-32-8
26
Estradiol125050-28-25757, 53477783
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17beta)-Estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
1,3,5[10]-Estratriene-3,17beta-diol 3-sulfate
1,3,5[10]-Estratriene-3,17beta-diol 3-sulphate
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta-Estradiol
17-.BETA.-Estradiol
17-E
17-beta
17-beta-OH-estradiol
17-beta-estradiol
17.beta.-Estradiol
17.beta.-Oestradiol
17E
17b-Estradiol
17b-Oestradiol
17beta Oestradiol
17beta oestradiol
17beta-Estra-1,3,5(10)-triene-3,17-diol
17beta-Estradiol
17beta-Oestradiol
1jgl
1qkt
1qku
2d06
3,17-Epidihydroxyestratriene
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulfate
3,17beta-dihydroxy-1,3,5[10]-estratriene 3-sulphate
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
B-Estradiol
BEDOs
BIDD:ER0125
BIDD:PXR0065
BPBio1_000532
BSPBio_000482
BSPBio_001065
Bardiol
Benzhormovarine
Beta-estradiol
Bio-0812
Bio-E-Gel
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
CMC_11154
CPD-352
CPD000059126
Climaderm
Climara
Climara (TN)
Climara Forte
Compudose
Compudose 200
Compudose 365
Corpagen
D-3,17beta-Estradiol
D-Estradiol
D-Oestradiol
D00105
DB00783
Dermestril
Destradiol
Dihydro-Theelin
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
Dihydrotheelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
EU-0100503
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
Estradiol
Estradiol [USAN:INN]
Estradiol-17 beta
Estradiol-17-beta
Estradiol-17.beta.
Estradiol-17beta
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
Estreva
Estrifam
Estring
Estring (TN)
Estring Vaginal Ring
Estring vaginal ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
Estrofem Forte
Estrogel
 
Estrogel (TN)
Estrogel HBF
Estrovite
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
GynPolar
Gynergon
Gynestrel
Gynodiol
Gynoestryl
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
LMST02010001
LS-137
Lamdiol
Lio-Oid
Lopac0_000503
MLS000069494
MLS000758312
MLS001076331
Macrodiol
Macrol
Menest
Menorest
Menostar
Microdiol
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
NSC-9895
NSC9895
Nordicol
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17-beta
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Prestwick_207
Primofol
Profoliol
Profoliol B
Progynon
Progynon DH
Progynon-DH
S-21400
S1709_Selleck
SAM001247032
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Sandrena 1
Sandrena Gel
Sisare Gel
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
VIVELLE-DOT
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
Zerella
Zesteem
Zesteen
Zumenon
[2,4,6,7-3H]-E2
[3H]-estradiol
[3H]]estradiol
b-Estradiol
beta-Estradiol
beta-Estradiol 3-sulfate
beta-Estradiol 3-sulphate
bmse000642
cMAP_000005
cis-Estradiol
cis-Oestradiol
component of Menrium
delta-Estradiol
delta-Oestradiol
estradiol
estradiol-17beta
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
progynon

Interventional clinical trials:

(show top 50)    (show all 77)
idNameStatusNCT IDPhase
1Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous PolyposisRecruitingNCT02175914Phase 4
2Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted VersionNot yet recruitingNCT02354560Phase 4
3A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)TerminatedNCT00140894Phase 4
4Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control PatientsTerminatedNCT00151476Phase 4
5Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPACompletedNCT00510692Phase 2, Phase 3
6Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous PolyposisCompletedNCT00808743Phase 2, Phase 3
7Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove PolypsCompletedNCT00005094Phase 3
8Clinical Approaches to Ileal Pouch DysfunctionCompletedNCT00293553Phase 3
9Australian Clinical Study of the Apnex Medical HGNS System to Treat Obstructive Sleep ApneaCompletedNCT01186926Phase 2, Phase 3
10Use of Post Operative Loperamide in Colorectal Patients After Diverting IleostomiesRecruitingNCT02263365Phase 3
11Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) PatientsActive, not recruitingNCT00134758Phase 2, Phase 3
12Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)Active, not recruitingNCT01483144Phase 3
13Compassionate Use of Ibalizumab for the Treatment of HIV InfectionAvailableNCT02028819Phase 3
14Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)TerminatedNCT00585312Phase 3
15Coxib-inhibition of Duodenal Polyp Growth in FAPTerminatedNCT00844727Phase 2, Phase 3
16A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)WithdrawnNCT01245816Phase 3
17Exisulind in Preventing Polyps in Patients With Familial Adenomatous PolyposisWithdrawnNCT00026468Phase 2, Phase 3
18A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis PatientsCompletedNCT01187901Phase 2
19Effects of Raw Versus Other Milk Sources on Lactose DigestionCompletedNCT01129791Phase 2
20Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous PolyposisRecruitingNCT00319007Phase 2
21The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled StudyRecruitingNCT01725490Phase 2
22A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type FibromatosisRecruitingNCT01265030Phase 1, Phase 2
23MLE4901 vs. Placebo for the Treatment of PCOSRecruitingNCT02865915Phase 2
24Treatment for Presumed Ocular HistoplasmosisRecruitingNCT01790893Phase 1, Phase 2
25Curcumin in Treating Patients With Familial Adenomatous PolyposisActive, not recruitingNCT00641147Phase 2
26Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal CancersActive, not recruitingNCT00503035Phase 2
27Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous PolyposisTerminatedNCT00033371Phase 2
28Outpatient Neutropenic Diet StudyTerminatedNCT00947648Phase 2
29Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis PatientsWithdrawnNCT00248053Phase 2
30Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CWCompletedNCT02113202Phase 1
31Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)CompletedNCT00770991Phase 1
32Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous PolyposisCompletedNCT00685568Phase 1
33A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy VolunteersCompletedNCT00813241Phase 1
34Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet ActionCompletedNCT02060396Phase 1
35Is Diverting Ileostomy Necessary in Stapled Ileoanal Pouch?CompletedNCT01173250
36A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner SyndromeCompletedNCT01286662
37Single Incision Laparoscopic Surgery in Treating Patients With Colorectal DiseaseCompletedNCT01656746
38Dual Focus NBI and pCLE in FAP Related Duodenal AdenomaCompletedNCT02162173
39Genetic Analysis of Hereditary Prostate CancerCompletedNCT00001469
40Endoscopic Papillectomy for Early Ampullary Tumors: Long-term Results of the First Large Multicenter Prospective StudyCompletedNCT01764503
41Oligogenic Determinism of Colorectal CancerCompletedNCT01057953
42Cidofovir as a Treatment for Herpes Simplex in Patients With AIDSCompletedNCT00002181
43Intervention to Retain HIV-positive Patients in Medical CareCompletedNCT01537367
44Ingenio Device Algorithm StudyCompletedNCT01441583
45Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Surveillance ProgramRecruitingNCT02747862
46Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis PatientsRecruitingNCT01604564
47Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)RecruitingNCT02656134
48Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)RecruitingNCT00927485
49Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer SyndromesRecruitingNCT02198092
50Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard EndoscopyRecruitingNCT00253812

Search NIH Clinical Center for Adenomatous Polyposis Coli

Inferred drug relations via UMLS66/NDF-RT44:

Genetic Tests for Adenomatous Polyposis Coli

About this section

Genetic tests related to Adenomatous Polyposis Coli:

id Genetic test Affiliating Genes
1 Familial Adenomatous Polyposis 125
2 Gardner Syndrome25 23 APC
3 Brain Tumor-Polyposis Syndrome 225

Anatomical Context for Adenomatous Polyposis Coli

About this section

MalaCards organs/tissues related to Adenomatous Polyposis Coli:

34
Colon, Skin, Thyroid, Brain, Liver, Bone, Adrenal gland

Animal Models for Adenomatous Polyposis Coli or affiliated genes

About this section

MGI Mouse Phenotypes related to Adenomatous Polyposis Coli:

39 (show all 14)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053718.2AMER1, APC, AXIN1, AXIN2, CTNNB1, MYC
2MP:00053828.1AMER1, APC, AXIN1, AXIN2, CCND1, CTNNB1
3MP:00053897.9APC, APC2, AXIN1, AXIN2, CCND1, CDH1
4MP:00028737.3APC, AXIN1, AXIN2, CCND1, CDH1, CTNNB1
5MP:00036317.2APC, APC2, AXIN1, AXIN2, CCND1, CTNNB1
6MP:00053817.2APC, AXIN1, CCND1, CDH1, CTNNB1, GSK3B
7MP:00053907.1AMER1, APC, ARHGEF4, AXIN1, AXIN2, CCND1
8MP:00020067.0APC, ARHGEF4, CCND1, CDH1, CTNNB1, IQGAP1
9MP:00053786.7AMER1, APC, APC2, AXIN1, AXIN2, CCND1
10MP:00053846.5AMER1, APC, APC2, ARHGEF4, AXIN1, AXIN2
11MP:00053856.3AMER1, APC, ARHGEF4, AXIN1, AXIN2, CCND1
12MP:00107686.0AMER1, APC, AXIN1, AXIN2, CCND1, CDH1
13MP:00053765.9AMER1, APC, ARHGEF4, CCND1, CDH1, CTNNB1

Publications for Adenomatous Polyposis Coli

About this section

Articles related to Adenomatous Polyposis Coli:

(show top 50)    (show all 297)
idTitleAuthorsYear
1
Adenomatous polyposis coli genotype-dependent toll-like receptor 4 activity in colon cancer. (26760960)
2016
2
Inactivation of Adenomatous Polyposis Coli Reduces Bile Acid/Farnesoid X Receptor Expression through Fxr gene CpG Methylation in Mouse Colon Tumors and Human Colon Cancer Cells. (26609171)
2016
3
Tumour Suppressor Adenomatous Polyposis Coli (APC) localisation is regulated by both Kinesin-1 and Kinesin-2. (27272132)
2016
4
Adenomatous polyposis coli mutants dominantly activate Hsf1-dependent cell stress pathways through inhibition of microtubule dynamics. (26320184)
2015
5
different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli. (24722208)
2014
6
5-Fluorouracil mediated anti-cancer activity in colon cancer cells is through the induction of Adenomatous Polyposis Coli: Implication of the long-patch base excision repair pathway. (25460919)
2014
7
Desmoid tumour biology in patients with familial adenomatous polyposis coli. (23334997)
2013
8
Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis. (22120905)
2012
9
Amer2 protein interacts with EB1 protein and adenomatous polyposis coli (APC) and controls microtubule stability and cell migration. (22898821)
2012
10
Adenomatous polyposis coli interacts with flap endonuclease 1 to block its nuclear entry and function. (22787431)
2012
11
Genotypes and phenotypes: animal models of familial adenomatous polyposis coli. (23010297)
2012
12
Structural basis for the recognition of Asef by adenomatous polyposis coli. (21788986)
2012
13
Adenomatous polyposis coli regulates axon arborization and cytoskeleton organization via its N-terminus. (21915313)
2011
14
Crystal structure of the armadillo repeat domain of adenomatous polyposis coli which reveals its inherent flexibility. (21871439)
2011
15
Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/I^-catenin signaling. (20971552)
2011
16
A novel pathogenic germline mutation in the adenomatous polyposis coli gene in a Tunisian family with FAP. (21598003)
2011
17
A novel frameshift mutation in exon 12 of the adenomatous polyposis coli gene in an Italian family with familial adenomatous polyposis and desmoid tumour. (20589194)
2010
18
Adenomatous polyposis coli and hypoxia-inducible factor-1{alpha} have an antagonistic connection. (20844082)
2010
19
Adenomatous polyposis coli and Asef function downstream of hepatocyte growth factor and phosphatidylinositol 3-kinase. (19525225)
2009
20
Risk of colorectal neoplasia associated with the adenomatous polyposis coli E1317Q variant. (19474113)
2009
21
Aberrant beta-catenin expression and adenomatous polyposis coli gene mutation in ameloblastoma and odontogenic carcinoma. (18486530)
2009
22
Recruitment of adenomatous polyposis coli and beta-catenin to axin-puncta. (18591934)
2008
23
Ligand-dependent interaction between estrogen receptor alpha and adenomatous polyposis coli. (18498351)
2008
24
Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. (18841156)
2008
25
Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by apigenin. (17620292)
2007
26
Cigarette smoke condensate-induced level of adenomatous polyposis coli blocks long-patch base excision repair in breast epithelial cells. (16924228)
2007
27
Structure/function analysis of the interaction of adenomatous polyposis coli with DNA polymerase beta and its implications for base excision repair. (17999539)
2007
28
Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells. (16982769)
2006
29
Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants. (16360415)
2006
30
Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases. (17028196)
2006
31
Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli. (16611247)
2006
32
Mechanism of adenomatous polyposis coli (APC)-mediated blockage of long-patch base excision repair. (17176113)
2006
33
Mutations of APC and MYH in unrelated Italian patients with adenomatous polyposis coli. (16134147)
2005
34
Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. (14679305)
2004
35
Cyclooxygenase 2 inhibitors and adenomatous polyposis coli]. (15899631)
2004
36
Novel germline mutations in the adenomatous polyposis coli gene in Polish families with familial adenomatous polyposis. (14729851)
2004
37
Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent. (15492264)
2004
38
Expressions of two adenomatous polyposis coli and E-cadherin proteins on human colorectal cancers. (12647217)
2003
39
Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein. (11972058)
2002
40
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. (11429699)
2001
41
Beta-catenin and adenomatous polyposis coli (APC) mutations in adenomas from hereditary non-polyposis colorectal cancer patients. (10936679)
2000
42
Role of the adenomatous polyposis coli gene product in human cardiac development and disease. (10749862)
2000
43
Comparative study of the expression of DNA mismatch repair genes, the adenomatous polyposis coli gene and growth arrest DNA damage genes in melanoma recurrences and metastases. (11198475)
2000
44
Mutations of the adenomatous polyposis coli and p53 genes in a child with Turcot's syndrome. (10397462)
1998
45
RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells. (9233623)
1997
46
Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. (8754807)
1996
47
Mutation detection in exons 1-14 of the adenomatous polyposis coli gene: identification of an alternatively spliced transcript. (8910893)
1996
48
The adenomatous polyposis coli gene and human cancers. (7559732)
1995
49
Analysis of adenomatous polyposis coli gene in thyroid tumours. (7981058)
1994
50
Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. (8252631)
1993

Variations for Adenomatous Polyposis Coli

About this section

UniProtKB/Swiss-Prot genetic disease variations for Adenomatous Polyposis Coli:

68 (show all 11)
id Symbol AA change Variation ID SNP ID
1APCp.Ser171IleVAR_005032
2APCp.Arg414CysVAR_005033rs137854567
3APCp.Ser784ThrVAR_005034
4APCp.Glu911GlyVAR_005038
5APCp.Pro1176LeuVAR_005044
6APCp.Thr1313AlaVAR_005051
7APCp.Arg1348TrpVAR_005053
8APCp.Ser2621CysVAR_005056rs72541816
9APCp.Leu2839PheVAR_005057
10APCp.Ser722GlyVAR_009614
11APCp.Ala1184ProVAR_009616

Clinvar genetic disease variations for Adenomatous Polyposis Coli:

5 (show all 113)
id Gene Variation Type Significance SNP ID Assembly Location
1APCNM_000038.5(APC): c.1213C> T (p.Arg405Ter)single nucleotide variantPathogenicrs587779780GRCh38Chr 5, 112819245: 112819245
2APCNM_000038.5(APC): c.2413C> T (p.Arg805Ter)single nucleotide variantPathogenicrs587779783GRCh38Chr 5, 112838007: 112838007
3APCNM_000038.5(APC): c.3088A> T (p.Lys1030Ter)single nucleotide variantPathogenicrs587779786GRCh38Chr 5, 112838682: 112838682
4APCNM_000038.5(APC): c.5934_5937delAAAC (p.Asn1979Thrfs)deletionPathogenicrs587781330GRCh37Chr 5, 112177225: 112177228
5APCNM_000038.5(APC): c.637C> T (p.Arg213Ter)single nucleotide variantPathogenicrs587781392GRCh37Chr 5, 112116592: 112116592
6APCNM_000038.5(APC): c.2004delC (p.Leu669Terfs)deletionPathogenicrs587782303GRCh37Chr 5, 112173295: 112173295
7APCNM_000038.5(APC): c.426_427delAT (p.Leu143Alafs)deletionPathogenicrs587782557GRCh38Chr 5, 112775632: 112775633
8APCNM_000038.5(APC): c.3286C> T (p.Gln1096Ter)single nucleotide variantPathogenicrs587783029GRCh38Chr 5, 112838880: 112838880
9APCNM_000038.5(APC): c.2107delG (p.Ala703Glnfs)deletionPathogenicrs587783030GRCh38Chr 5, 112837701: 112837701
10APCNM_000038.5(APC): c.4666delA (p.Thr1556Leufs)deletionPathogenicrs587783031GRCh38Chr 5, 112840260: 112840260
11APCNM_000038.5(APC): c.3814delT (p.Ser1272Glnfs)deletionPathogenicrs587783033GRCh38Chr 5, 112839408: 112839408
12APCNM_000038.5(APC): c.1744-2A> Gsingle nucleotide variantPathogenicrs587783035GRCh38Chr 5, 112834949: 112834949
13APCNC_000005.10: g.(?_112754891)_(112844071_?)deldeletionPathogenicGRCh37Chr 5, 112090588: 112179768
14APCNM_000038.5(APC): c.4255delA (p.Ser1419Alafs)deletionLikely pathogenicrs727504420GRCh37Chr 5, 112175546: 112175546
15APCNM_000038.5(APC): c.477delC (p.Tyr159Terfs)deletionPathogenicrs730880250GRCh37Chr 5, 112111380: 112111380
16APCNM_000038.5(APC): c.1312+3_1312+4delATdeletionPathogenicrs730881228GRCh38Chr 5, 112819347: 112819348
17APCNM_000038.5(APC): c.5490_5493delTGAA (p.Asn1830Lysfs)deletionPathogenicrs730881273GRCh38Chr 5, 112841084: 112841087
18APCNM_000038.5(APC): c.3149delC (p.Ala1050Glufs)deletionPathogenicrs730882135GRCh38Chr 5, 112838743: 112838743
19APCNM_000038.5(APC): c.70C> T (p.Arg24Ter)single nucleotide variantPathogenicrs145945630GRCh37Chr 5, 112090657: 112090657
20APCNM_000038.5(APC): c.847C> T (p.Arg283Ter)single nucleotide variantPathogenicrs786201856GRCh37Chr 5, 112151204: 112151204
21APCNM_000038.5(APC): c.3471_3474delGAGA (p.Glu1157Aspfs)deletionPathogenicrs786203020GRCh37Chr 5, 112174762: 112174765
22APCNM_000038.5(APC): c.925G> T (p.Gly309Ter)single nucleotide variantPathogenicrs786204118GRCh37Chr 5, 112151282: 112151282
23APCNM_000038.5(APC): c.3830T> G (p.Leu1277Ter)single nucleotide variantPathogenicrs786204169GRCh37Chr 5, 112175121: 112175121
24APCNM_000038.5(APC): c.4175C> A (p.Ser1392Ter)single nucleotide variantPathogenicrs786204170GRCh37Chr 5, 112175466: 112175466
25APCNM_000038.5(APC): c.1262G> A (p.Trp421Ter)single nucleotide variantPathogenicrs559510809GRCh38Chr 5, 112819294: 112819294
26APCNM_000038.5(APC): c.2563_2564delGA (p.Glu855Thrfs)deletionPathogenicrs794727160GRCh37Chr 5, 112173854: 112173855
27APCNM_000038.5(APC): c.4348C> T (p.Arg1450Ter)single nucleotide variantPathogenicrs121913332GRCh37Chr 5, 112175639: 112175639
28APCNM_000038.5(APC): c.1072C> T (p.Gln358Ter)single nucleotide variantPathogenicrs863224455GRCh37Chr 5, 112154801: 112154801
29APCNM_000038.5(APC): c.1409-?_*(1_?)deldeletionPathogenicGRCh38Chr 5, 112827108: 112844127
30APCNM_000038.5(APC): c.2626C> T (p.Arg876Ter)single nucleotide variantPathogenicrs121913333GRCh37Chr 5, 112173917: 112173917
31APCNM_000038.5(APC): c.3921_3924delAAAA (p.Ile1307Metfs)deletionPathogenicrs863224457GRCh37Chr 5, 112175212: 112175215
32APCNM_000038.5(APC): c.423G> T (p.Arg141Ser)single nucleotide variantPathogenicrs863224458GRCh37Chr 5, 112111326: 112111326
33APCNM_000038.5(APC): c.791delA (p.Gly265Glufs)deletionPathogenicrs863224459GRCh37Chr 5, 112137037: 112137037
34APCNM_000038.5(APC): c.1886dupT (p.Leu629Phefs)duplicationPathogenicrs863224817GRCh38Chr 5, 112835093: 112835093
35APCNM_000038.5(APC): c.453delA (p.Glu152Lysfs)deletionPathogenicrs863224820GRCh37Chr 5, 112111356: 112111356
36APCNM_000038.5(APC): c.1312+3A> Gsingle nucleotide variantLikely pathogenic, Pathogenicrs863225311GRCh37Chr 5, 112155044: 112155044
37APCNM_000038.5(APC): c.1892_1904delTTATTGAAAGTGGinsAAT (p.Ile631Lysfs)indelLikely pathogenic, Pathogenicrs863225319GRCh38Chr 5, 112835099: 112835111
38APCNM_000038.5(APC): c.1972_1975delGAGA (p.Glu658Thrfs)deletionPathogenicrs863225322GRCh37Chr 5, 112173263: 112173266
39APCNM_000038.5(APC): c.423-?_531+?deldeletionPathogenic
40APCNM_000038.5(APC): c.5145delC (p.Asp1715Glufs)deletionPathogenicrs863225363GRCh38Chr 5, 112840739: 112840739
41APCNM_000038.5(APC): c.645+1G> Asingle nucleotide variantLikely pathogenic, Pathogenicrs863225370GRCh37Chr 5, 112116601: 112116601
42APCNM_000038.5(APC): c.3404_3405delAT (p.Tyr1135Terfs)deletionPathogenicrs864622086GRCh38Chr 5, 112838998: 112838999
43APCNM_000038.5(APC): c.3595_3596delAA (p.Lys1199Glufs)deletionPathogenicrs864622106GRCh38Chr 5, 112839189: 112839190
44APCNM_000038.5(APC): c.5826_5829delCAGA (p.Asp1942Glufs)deletionPathogenicrs864622228GRCh38Chr 5, 112841420: 112841423
45APCNM_000038.5(APC): c.3925_3928delGAAA (p.Glu1309Argfs)deletionPathogenicrs876659647GRCh37Chr 5, 112175216: 112175219
46APCNM_000038.5(APC): c.4717delG (p.Glu1573Lysfs)deletionPathogenicrs878853217GRCh38Chr 5, 112840311: 112840311
47APCNM_000038.5(APC): c.-85-?_*2113+?deldeletionPathogenic
48APCNM_000038.5(APC): c.1743+1G> Asingle nucleotide variantLikely pathogenicrs761458613GRCh38Chr 5, 112828973: 112828973
49APCNM_000038.5(APC): c.1866_1867delCCinsAT (p.Tyr622Ter)indelPathogenicrs878853419GRCh38Chr 5, 112835073: 112835074
50APCNM_000038.5(APC): c.1875_1878delGACA (p.Asn627Leufs)deletionPathogenicrs878853420GRCh38Chr 5, 112835082: 112835085
51APCNM_000038.5(APC): c.2031_2034delCAGT (p.Ser678Metfs)deletionPathogenicrs878853422GRCh37Chr 5, 112173322: 112173325
52APCNM_000038.5(APC): c.2314delA (p.Thr772Leufs)deletionPathogenicrs878853426GRCh38Chr 5, 112837908: 112837908
53APCNM_000038.5(APC): c.249delT (p.Gly84Glufs)deletionPathogenicrs878853428GRCh38Chr 5, 112767217: 112767217
54APCNM_000038.5(APC): c.2795C> G (p.Ser932Ter)single nucleotide variantPathogenicrs878853432GRCh37Chr 5, 112174086: 112174086
55APCNM_000038.5(APC): c.3196delA (p.Arg1066Aspfs)deletionPathogenicrs878853436GRCh38Chr 5, 112838790: 112838790
56APCNM_000038.5(APC): c.3340C> T (p.Arg1114Ter)single nucleotide variantPathogenicrs121913331GRCh37Chr 5, 112174631: 112174631
57APCNM_000038.5(APC): c.3391C> T (p.Gln1131Ter)single nucleotide variantPathogenicrs878853438GRCh38Chr 5, 112838985: 112838985
58APCNM_000038.5(APC): c.448A> T (p.Lys150Ter)single nucleotide variantPathogenicrs878853444GRCh38Chr 5, 112775654: 112775654
59APCNM_000038.5(APC): c.4701delA (p.Asp1568Metfs)deletionPathogenicrs878853449GRCh38Chr 5, 112840295: 112840295
60APCNM_000038.5(APC): c.476dupA (p.Tyr159Terfs)duplicationPathogenicrs878853451GRCh37Chr 5, 112111379: 112111379
61APCNM_000038.5(APC): c.4987G> T (p.Glu1663Ter)single nucleotide variantPathogenicrs758987855GRCh37Chr 5, 112176278: 112176278
62APCNM_000038.5(APC): c.5025dupT (p.Arg1676Terfs)duplicationPathogenicrs878853454GRCh37Chr 5, 112176316: 112176316
63APCNM_000038.5(APC): c.5917delA (p.Ser1973Valfs)deletionPathogenicrs878853458GRCh37Chr 5, 112177208: 112177208
64APCNM_000038.5(APC): c.595dupG (p.Ala199Glyfs)duplicationPathogenicrs878853459GRCh37Chr 5, 112116550: 112116550
65APCNM_000038.5(APC): c.6610C> T (p.Arg2204Ter)single nucleotide variantLikely pathogenicrs752654519GRCh38Chr 5, 112842204: 112842204
66APCNM_000038.5(APC): c.934-?_*2113+?deldeletionPathogenic
67APCNM_001127511.2(APC): c.-191T> Csingle nucleotide variantPathogenicrs879253783GRCh38Chr 5, 112707527: 112707527
68APCNM_001127511.2(APC): c.-192A> Gsingle nucleotide variantPathogenicrs879253784GRCh38Chr 5, 112707526: 112707526
69APCNM_001127511.2(APC): c.-192A> Tsingle nucleotide variantPathogenicrs879253784GRCh38Chr 5, 112707526: 112707526
70APCNM_001127511.2(APC): c.-190G> Asingle nucleotide variantPathogenicrs879253785GRCh38Chr 5, 112707528: 112707528
71APCNM_000038.5(APC): c.1917dupA (p.Arg640Thrfs)duplicationLikely pathogenicrs397515732GRCh37Chr 5, 112170821: 112170821
72APCNM_000038.5(APC): c.3162delC (p.His1054Glnfs)deletionPathogenicrs397515733GRCh37Chr 5, 112174453: 112174453
73APCNM_000038.5(APC): c.694C> T (p.Arg232Ter)single nucleotide variantPathogenicrs397515734GRCh37Chr 5, 112128191: 112128191
74APCNM_000038.5(APC): c.896_897delCT (p.Ser299Cysfs)deletionPathogenicrs397515735GRCh37Chr 5, 112151253: 112151254
75APCNM_000038.5(APC): c.730_731delAG (p.Arg244Valfs)deletionPathogenicrs387906228GRCh37Chr 5, 112136976: 112136977
76APCNM_000038.5(APC): c.1369delT (p.Ser457Hisfs)deletionPathogenicrs387906229GRCh37Chr 5, 112157649: 112157649
77APCNM_000038.5(APC): c.1500T> G (p.Tyr500Ter)single nucleotide variantPathogenicrs387906230GRCh37Chr 5, 112162896: 112162896
78APCNM_000038.5(APC): c.904C> T (p.Arg302Ter)single nucleotide variantPathogenicrs137854568GRCh37Chr 5, 112151261: 112151261
79APCNM_000038.5(APC): c.4012C> T (p.Gln1338Ter)single nucleotide variantPathogenicrs121913327GRCh37Chr 5, 112175303: 112175303
80APCNM_000038.5(APC): c.509_512delATAG (p.Asp170Valfs)deletionPathogenicrs387906231GRCh37Chr 5, 112111412: 112111415
81APCNM_000038.5(APC): c.1069dupA (p.Ile357Asnfs)duplicationPathogenicrs387906232GRCh37Chr 5, 112154798: 112154798
82APCNM_000038.5(APC): c.1621C> T (p.Gln541Ter)single nucleotide variantPathogenicrs137854572GRCh37Chr 5, 112163698: 112163698
83APCNM_000038.5(APC): c.1660C> T (p.Arg554Ter)single nucleotide variantPathogenicrs137854573GRCh37Chr 5, 112164586: 112164586
84APCNM_000038.5(APC): c.1690C> T (p.Arg564Ter)single nucleotide variantPathogenicrs137854574GRCh37Chr 5, 112164616: 112164616
85APCNM_000038.5(APC): c.1885_1886insA (p.Leu629Tyrfs)insertionPathogenicrs387906233GRCh37Chr 5, 112170789: 112170790
86APCNM_000038.5(APC): c.2805C> A (p.Tyr935Ter)single nucleotide variantPathogenicrs137854575GRCh37Chr 5, 112174096: 112174096
87APCNM_000038.5(APC): c.470G> A (p.Trp157Ter)single nucleotide variantPathogenicrs137854576GRCh37Chr 5, 112111373: 112111373
88APCNM_000038.5(APC): c.643C> T (p.Gln215Ter)single nucleotide variantPathogenicrs137854577GRCh37Chr 5, 112116598: 112116598
89NC_000005.10: g.112836913_112908314del71402deletionPathogenicGRCh37Chr 5, 112172610: 112244011
90APCNM_000038.5(APC): c.3927_3931delAAAGA (p.Glu1309Aspfs)deletionPathogenicrs121913224GRCh37Chr 5, 112175218: 112175222
91APCNM_000038.5(APC): c.5942delA (p.Asn1981Ilefs)deletionPathogenicrs397509433GRCh37Chr 5, 112177233: 112177233
92APCNM_000038.5(APC): c.5582_5585delCTTT (p.Ser1861Terfs)deletionPathogenicrs587776520GRCh38Chr 5, 112841176: 112841179
93APCNM_000038.5(APC): c.3920T> A (p.Ile1307Lys)single nucleotide variantPathogenic, risk factorrs1801155GRCh37Chr 5, 112175211: 112175211
94APCNM_000038.5(APC): c.1495C> T (p.Arg499Ter)single nucleotide variantPathogenicrs137854580GRCh37Chr 5, 112162891: 112162891
95APCAPC, TYR486TERsingle nucleotide variantPathogenic
96APCNM_000038.5(APC): c.1311_1312+1delAAGdeletionPathogenicrs397514030GRCh37Chr 5, 112155040: 112155042
97APCNM_000038.5(APC): c.1098_1099delCT (p.Ser367Cysfs)deletionPathogenicrs387906237GRCh37Chr 5, 112154827: 112154828
98APCNM_000038.5(APC): c.1192_1193delAA (p.Lys398Glufs)deletionPathogenicrs387906238GRCh37Chr 5, 112154921: 112154922
99APCNM_000038.5(APC): c.937_938delGA (p.Glu313Asnfs)deletionPathogenicrs387906239GRCh37Chr 5, 112154666: 112154667
100APCAPC deletiondeletionPathogenicGRCh38Chr 5, 112707504: 112846240
101APCNM_000038.5(APC): c.423-1G> Asingle nucleotide variantPathogenicrs397514031GRCh37Chr 5, 112111325: 112111325
102APCAPC, 11-BP INS, NT1060insertionPathogenic
103APCNG_008481.4: g.(?_150033)_(158719_?)deldeletionPathogenicGRCh38Chr 5, 112837553: 112846239
104APCAPC, 5-BP DEL, NT3221deletionPathogenic
105APCNM_000038.5(APC): c.3183_3187delACAAA (p.Gln1062Terfs)deletionPathogenicrs587779352GRCh37Chr 5, 112174474: 112174478
106APCNM_000038.5(APC): c.3202_3205delTCAA (p.Ser1068Glyfs)deletionPathogenicrs587779353GRCh37Chr 5, 112174493: 112174496
107APCNM_000038.5(APC): c.1659G> A (p.Trp553Ter)single nucleotide variantPathogenicrs398123116GRCh37Chr 5, 112164585: 112164585
108APCNM_000038.5(APC): c.2365C> T (p.Gln789Ter)single nucleotide variantPathogenicrs398123117GRCh37Chr 5, 112173656: 112173656
109APCNM_000038.5(APC): c.2547_2550delTAGA (p.Asp849Glufs)deletionPathogenicrs398123118GRCh37Chr 5, 112173838: 112173841
110APCNM_000038.5(APC): c.2731G> T (p.Glu911Ter)single nucleotide variantPathogenicrs398123119GRCh37Chr 5, 112174022: 112174022
111APCNM_000038.5(APC): c.2805delC (p.Tyr935Terfs)deletionPathogenicrs398123120GRCh37Chr 5, 112174096: 112174096
112APCNM_000038.5(APC): c.3982C> T (p.Gln1328Ter)single nucleotide variantPathogenicrs398123121GRCh37Chr 5, 112175273: 112175273
113APCNM_000038.5(APC): c.4473dupT (p.Ala1492Cysfs)duplicationPathogenicrs398123122GRCh38Chr 5, 112840067: 112840067

Expression for genes affiliated with Adenomatous Polyposis Coli

About this section
Search GEO for disease gene expression data for Adenomatous Polyposis Coli.

Pathways for genes affiliated with Adenomatous Polyposis Coli

About this section

Pathways related to Adenomatous Polyposis Coli according to GeneCards Suite gene sharing:

(show all 50)
idSuper pathwaysScoreTop Affiliating Genes
19.7APC, GSK3B, MAPRE1
29.6AXIN1, CTNNB1, MAPRE1
3
Show member pathways
9.4APC, AXIN1, CTNNB1, GSK3B
49.3AXIN1, GSK3B, MYC
59.3CCND1, CTNNB1, GSK3B
6
Show member pathways
9.2AXIN1, AXIN2, CTNNB1, GSK3B
79.1CCND1, CTNNB1, MYC
8
Show member pathways
9.0APC, AXIN1, AXIN2, CTNNB1, GSK3B
98.9CDH1, CTNNB1, IQGAP1
108.9CDH1, CTNNB1, IQGAP1
118.9CDH1, CTNNB1, IQGAP1
128.9APC, AXIN1, CDH1, CTNNB1, GSK3B
138.9APC, AXIN1, CDH1, CTNNB1, GSK3B
148.9APC, APC2, CCND1, MYC
158.9CCND1, CDH1, MYC
168.9APC, ARHGEF4, AXIN1, CTNNB1, GSK3B
178.9APC, CCND1, CTNNB1, MYC
18
Show member pathways
8.8APC, APC2, AXIN1, AXIN2, CTNNB1, GSK3B
198.8AMER1, APC, AXIN1, AXIN2, CTNNB1, GSK3B
20
Show member pathways
8.8AMER1, APC, AXIN1, AXIN2, CTNNB1, GSK3B
218.8CCND1, CTNNB1, GSK3B, MYC
22
Show member pathways
8.8CCND1, CTNNB1, GSK3B, MYC
23
Show member pathways
8.7APC, ARHGEF4, CDH1, CTNNB1, GSK3B
24
Show member pathways
8.6AMER1, APC, AXIN1, CTNNB1, GSK3B, MYC
258.6CCND1, CDH1, CTNNB1, MYC
268.6CCND1, CDH1, CTNNB1, MYC
278.6CCND1, CDH1, GSK3B, MYC
288.5CCND1, IQGAP1, MYC
29
Show member pathways
8.4APC, CDH1, CTNNB1, GSK3B, IQGAP1
308.4AXIN1, AXIN2, CCND1, CTNNB1, MYC
318.3APC, APC2, CCND1, CTNNB1, GSK3B, MYC
32
Show member pathways
8.3AXIN1, CDH1, CTNNB1, GSK3B, IQGAP1
338.3CCND1, CDH1, CTNNB1, IQGAP1
34
Show member pathways
8.3CCND1, CDH1, CTNNB1, GSK3B, MYC
358.3APC, APC2, AXIN1, AXIN2, CTNNB1, GSK3B
36
Show member pathways
8.2AMER1, APC, AXIN1, AXIN2, CTNNB1, GSK3B
378.2CCND1, CTNNB1, IQGAP1, MYC
388.2APC, AXIN1, CCND1, CTNNB1, GSK3B, MYC
398.2APC, AXIN1, CCND1, CTNNB1, GSK3B, MYC
408.2AXIN1, AXIN2, CDH1, CTNNB1, GSK3B, MYC
418.0APC, AXIN2, CCND1, CDH1, CTNNB1, MYC
428.0CDH1, CTNNB1, IQGAP1, MAPRE1, MAPRE2, MAPRE3
43
Show member pathways
7.9APC, AXIN1, AXIN2, CCND1, CTNNB1, GSK3B
447.8APC, AXIN1, CCND1, CDH1, CTNNB1, GSK3B
457.7APC, AXIN2, CCND1, CDH1, CTNNB1, GSK3B
46
Show member pathways
7.2APC, APC2, AXIN1, AXIN2, CCND1, CDH1
47
Show member pathways
7.2APC, APC2, AXIN1, AXIN2, CCND1, CDH1
487.2APC, APC2, AXIN1, AXIN2, CCND1, CDH1
497.2APC, APC2, AXIN1, AXIN2, CCND1, CDH1
50
Show member pathways
5.5AMER1, APC, ARHGEF4, AXIN1, AXIN2, CCND1

GO Terms for genes affiliated with Adenomatous Polyposis Coli

About this section

Cellular components related to Adenomatous Polyposis Coli according to GeneCards Suite gene sharing:

(show all 18)
idNameGO IDScoreTop Affiliating Genes
1cell projection membraneGO:003125310.5CTNNB1, MAPRE1
2flotillin complexGO:001660010.4CDH1, CTNNB1
3apical junction complexGO:004329610.4CDH1, CTNNB1
4Wnt signalosomeGO:199090910.3APC, CTNNB1, GSK3B
5microtubule plus-endGO:003537110.2MAPRE1, MAPRE2, MAPRE3
6ruffle membraneGO:003258710.0APC, ARHGEF4, SPATA13
7catenin complexGO:001634210.0APC, APC2, CDH1, CTNNB1
8bicellular tight junctionGO:00059239.9APC, CCND1, CTNNB1
9cytoplasmic microtubuleGO:00058819.7APC, APC2, AXIN1, AXIN2, MAPRE1
10lamellipodiumGO:00300279.6APC, CDH1, CTNNB1, SPATA13
11centrosomeGO:00058139.6APC, AXIN2, CTNNB1, GSK3B, MAPRE1
12beta-catenin destruction complexGO:00308779.4APC, APC2, AXIN1, AXIN2, CTNNB1, GSK3B
13cell cortexGO:00059389.2APC, AXIN1, AXIN2, CTNNB1
14cell-cell adherens junctionGO:00059138.9APC, CDH1, CTNNB1, IQGAP1, MAPRE1
15microtubule cytoskeletonGO:00156308.6APC2, AXIN2, IQGAP1, MAPRE1, MAPRE2, MAPRE3
16lateral plasma membraneGO:00163288.5APC, AXIN1, CDH1, CTNNB1, IQGAP1
17cytosolGO:00058295.9AMER1, APC, ARHGEF4, AXIN1, AXIN2, CCND1
18cytoplasmGO:00057375.0APC, APC2, AXIN1, AXIN2, CCND1, CDH1

Biological processes related to Adenomatous Polyposis Coli according to GeneCards Suite gene sharing:

(show all 32)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of microtubule plus-end bindingGO:190303310.5MAPRE1, MAPRE3
2negative regulation of catenin import into nucleusGO:003541410.4APC2, AXIN2
3regulation of microtubule-based processGO:003288610.4APC, GSK3B
4regulation of centromeric sister chromatid cohesionGO:007060210.4AXIN2, CTNNB1
5regulation of cell differentiationGO:004559510.3APC, APC2, CTNNB1
6cell fate specificationGO:000170810.3APC, APC2, CTNNB1
7positive regulation of mitochondrial membrane potentialGO:001091810.3GSK3B, MYC
8protein localization to microtubuleGO:003537210.3GSK3B, MAPRE1
9cellular response to indole-3-methanolGO:007168110.3CDH1, CTNNB1
10Wnt signaling pathway involved in somitogenesisGO:009024410.2AXIN1, AXIN2
11filopodium assemblyGO:004684710.1ARHGEF4, SPATA13
12positive regulation of DNA biosynthetic processGO:200057310.1GSK3B, MYC
13dorsal/ventral axis specificationGO:000995010.1AXIN1, AXIN2, CTNNB1
14cellular response to lithium ionGO:007128510.0CDH1, CTNNB1, GSK3B
15beta-catenin destruction complex assemblyGO:190488510.0AMER1, APC, AXIN1, GSK3B
16positive regulation of protein catabolic processGO:004573210.0APC, APC2, AXIN1, GSK3B
17response to angiotensinGO:19907769.9GSK3B, IQGAP1
18beta-catenin-TCF complex assemblyGO:19048379.9AXIN2, CTNNB1, MYC
19cellular response to organic cyclic compoundGO:00714079.8AXIN1, AXIN2, MYC
20beta-catenin destruction complex disassemblyGO:19048869.7AMER1, APC, AXIN1, CTNNB1, GSK3B
21re-entry into mitotic cell cycleGO:00003209.7CCND1, GSK3B, MYC
22cell migrationGO:00164779.6APC, APC2, GSK3B, SPATA13
23proteasome-mediated ubiquitin-dependent protein catabolic processGO:00431619.6AMER1, APC, AXIN1, CTNNB1, GSK3B
24cellular response to fibroblast growth factor stimulusGO:00443449.3CTNNB1, IQGAP1, MYC
25negative regulation of canonical Wnt signaling pathwayGO:00900909.2AMER1, APC, APC2, AXIN1, AXIN2, GSK3B
26response to estradiolGO:00323559.0CCND1, CTNNB1, GSK3B, MYC
27positive regulation of transcription, DNA-templatedGO:00458938.9AXIN1, CDH1, CTNNB1, MAPRE3, MYC
28canonical Wnt signaling pathwayGO:00600708.6APC, AXIN1, CCND1, CTNNB1, GSK3B, MYC
29cell proliferationGO:00082838.5APC2, AXIN2, CTNNB1, GLUL, MAPRE1, MAPRE2
30response to drugGO:00424938.1APC, CCND1, CDH1, CTNNB1, GSK3B, MYC
31positive regulation of GTPase activityGO:00435477.9ARHGEF4, AXIN1, AXIN2, GSK3B, IQGAP1, SPATA13
32Wnt signaling pathwayGO:00160557.8AMER1, APC, APC2, AXIN1, AXIN2, CCND1

Molecular functions related to Adenomatous Polyposis Coli according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1microtubule plus-end bindingGO:005101010.7APC, MAPRE1
2armadillo repeat domain bindingGO:007001610.4AXIN1, AXIN2
3Rac guanyl-nucleotide exchange factor activityGO:003067610.2ARHGEF4, SPATA13
4I-SMAD bindingGO:007041110.1AXIN1, AXIN2, CTNNB1
5gamma-catenin bindingGO:004529510.1APC, APC2, CDH1
6microtubule bindingGO:00080179.6APC, APC2, MAPRE2, MAPRE3
7cadherin binding involved in cell-cell adhesionGO:00986419.1CDH1, CTNNB1, IQGAP1, MAPRE1
8beta-catenin bindingGO:00080138.9AMER1, APC, APC2, AXIN1, AXIN2, CDH1
9protein complex bindingGO:00324038.4APC, CCND1, CTNNB1, IQGAP1, MYC
10protein kinase bindingGO:00199017.9APC, AXIN1, AXIN2, CCND1, CTNNB1, GSK3B
11protein bindingGO:00055153.9AMER1, APC, APC2, ARHGEF4, AXIN1, AXIN2

Sources for Adenomatous Polyposis Coli

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet